United States · FDA National Drug Code directory
ATORVASTATIN CALCIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-2671_68d09be6-1a04-4117-85dc-1d975e475c6a
- Product NDC
- 60505-2671
- Form
- TABLET, FILM COATED
- Composition / generic term
- ATORVASTATIN CALCIUM
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120529
- Source listing expiry
- 20271231
Source-listed ingredients
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (60505-2671-0) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 60505-2671-0
- 30 TABLET, FILM COATED in 1 BOTTLE (60505-2671-3) · 60505-2671-3
- 500 TABLET, FILM COATED in 1 BOTTLE (60505-2671-5) · 60505-2671-5
- 2500 TABLET, FILM COATED in 1 BOTTLE (60505-2671-7) · 60505-2671-7
- 1000 TABLET, FILM COATED in 1 BOTTLE (60505-2671-8) · 60505-2671-8
- 90 TABLET, FILM COATED in 1 BOTTLE (60505-2671-9) · 60505-2671-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →